AI engineers nanoparticles for improved drug delivery
Peer-Reviewed Publication
Updates every hour. Last Updated: 7-Oct-2025 10:11 ET (7-Oct-2025 14:11 GMT/UTC)
Biomedical engineers at Duke University have developed a platform that combines automated wet lab techniques with artificial intelligence (AI) to design nanoparticles for drug delivery. The approach could help researchers deliver difficult-to-encapsulate therapeutics more efficiently and effectively.
The protein on human cells that tick-borne encephalitis virus (TBEV) uses for infection has now been identified—a major step toward understanding how TBEV causes neurological disease and for developing antiviral drugs. The study, co-led by scientists at Albert Einstein College of Medicine, Karolinska Institutet, and the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) published today in the journal Nature.